TrialNature communications2025

Regorafenib plus sintilimab as a salvage treatment for microsatellite stable metastatic colorectal cancer: a single-arm, open-label, phase II clinical trial.

Rui Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.